Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04147884 · ClinicalTrials.gov registry record · NA
A Feasibility Study of the Millipede Transcatheter Annuloplasty Ring System in Patients With Functional Mitral Regurgitation
A NA study of Cardiovascular Diseases and Mitral Valve Disease, sponsored by Boston Scientific Corporation.
- Active
- Registry status
- NA
- Development phase
- 4
- Enrollment target
- 4
- Study locations
NCT04147884: Active NA study of Cardiovascular Diseases and Mitral Valve Disease, sponsored by Boston Scientific Corporation.
NCT04147884 is a NA study of Cardiovascular Diseases and Mitral Valve Disease that is active but no longer recruiting, run by Boston Scientific Corporation. The registered enrollment target is 4 participants, below the 26,974-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (100% lower). The trial reports 4 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04147884, a NA study of Cardiovascular Diseases and Mitral Valve Disease, is active but no longer recruiting, sponsored by Boston Scientific Corporation.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 4 participants
- Enrollment target
- 4
- Study locations
Study Summary
To evaluate the feasibility and safety of the Millipede Transcatheter Annuloplasty Ring System in subjects with functional mitral regurgitation
Primary Outcome
Technical Success (measured at exit from the catheterization laboratory) is defined per Mitral Valve Academic Research Consortium (MVARC ). All of the following must be present: Absence of procedural mortality; and Successful access, delivery and retrieval of the device delivery system; and Successful deployment and correct positioning of the first intended device; and Freedom from emergency surgery or reintervention related to the device or access procedure.
Conditions Studied
Interventions
- DEVICE Millipede Transcatheter Annuloplasty Ring System (Millipede System)
Study Locations (4)
New York
- Columbia University Medical Center/New York Presbyterian Hospital - New York
- Montefiore Medical Center - The Bronx
Arizona
- Tucson Medical Center Healthcare - Tucson
Victoria
- Monash Health - Clayton
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2019-11-13 |
| Est. Completion | 2026-11 |
| Phase | NA |
What the registry record for NCT04147884 still lists
NCT04147884 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 4 participants, a relatively small participant target, below the 26,974-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (100% lower).
The record links to 3 conditions, with Cardiovascular Diseases appearing as the primary indexed condition, and to 1 intervention - of which Millipede Transcatheter Annuloplasty Ring System (Millipede System) is the first listed.
NCT04147884 reports a single indexed study location in New York, Arizona, Victoria.
Frequently Asked Questions
What is clinical trial NCT04147884 about?
NCT04147884 is a clinical study titled "A Feasibility Study of the Millipede Transcatheter Annuloplasty Ring System in Patients With Functional Mitral Regurgitation". To evaluate the feasibility and safety of the Millipede Transcatheter Annuloplasty Ring System in subjects with functional mitral regurgitation
What is the current status of trial NCT04147884?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 4 participants. The study started on 2019-11-13. Estimated completion is 2026-11.
What conditions does trial NCT04147884 study?
This clinical trial studies the following conditions: Cardiovascular Diseases, Mitral Valve Disease, Mitral Regurgitation Functional.
What interventions are being tested in trial NCT04147884?
The interventions under investigation include: Millipede Transcatheter Annuloplasty Ring System (Millipede System) (DEVICE).
Who is sponsoring clinical trial NCT04147884?
This trial is sponsored by Boston Scientific Corporation, which has 280 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04147884 being conducted?
This trial has 4 study locations across Arizona, New York, Victoria. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cardiovascular Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04147884's enrollment target sits among peer trials
4 301st of 300 the lowest of 300 other Cardiovascular Diseases trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cardiovascular Diseases trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
The Influence of Chardonnay Marc Intake on Gut and Cardiometabolic Health
RECRUITING · NA
-
Identifying Strategies to Reduce Cardiovascular Risk Among Mothers of Young Children
RECRUITING · NA
-
Insomnia Treatment and Cardiometabolic Health in Older Adults With Posttraumatic Stress Disorder
RECRUITING · NA
-
Deep Brain Stimulation Motor Ventral Thalamus (VOP/VIM) for Restoration of Speech and Upper-limb Function in People With Subcortical Stroke
RECRUITING · NA
-
Effects of Whole vs. Nonfat Milk Consumption on Body Composition in Children
RECRUITING · NA
-
MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI